Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The innate defense system of the female mucosal genital tract involves a close and complex interaction among the healthy vaginal microbiota, different cells and various proteins that protect the host from pathogens. Vaginal lactobacilli and lactoferrin represent two essential actors in the vaginal environment. Lactobacilli represent the dominant bacterial species able to prevent facultative and obligate anaerobes outnumber in vaginal microbiota maintaining healthy microbial homeostasis. Several mechanisms underlie the protection exerted by lactobacilli: competition for nutrients and tissue adherence, reduction of the vaginal pH, modulation of immunity and production of bioactive compounds. Among bioactive factors of cervicovaginal mucosa, lactoferrin, an iron binding cationic glycoprotein, is a multifunctional glycoprotein with antibacterial, antifungal, antiviral, antiparasitic activity, recently emerging as an important modulator of inflammation. Lactobacilli and lactoferrin are largely under the influence female hormones and of paracrine production of various cytokines. Lactoferrin is strongly increased in lower genital tract mucosal fluid of women affected by Neisseria gonorrheae, Chlamydia trachomatis and Trichomonas vaginalis infections promoting both innate and adaptive immune responses. In vaginal dysbiosis characterized by low amounts of vaginal lactobacilli and increased levels of endogenous anaerobic bacteria the increase of lactoferrin could act as an immune modulator assuming the role normally played by the healthy microbiota in vaginal mucosa. Then lactoferrin and lactobacilli may be considered as biomarkers of altered microbial homeostasis at vaginal level. Considering the shortage of effective treatments to counteract recurrent and/or antibiotic-resistant bacterial infections, the intravaginal administration of lactobacilli and lactoferrin could be a novel efficient therapeutic strategy and a valuable tool to restore mucosal immune homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960 · cited 2×
“Niyonsaba F, Ogawa H. Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents β-defensins, cathelicidin LL-37 and lysozyme.”
BackgroundA component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026 · cited 1×
“The low iron availability (10–18 M), hindering microbial growth, is a signal of health and wellness, while iron concentration higher than 10–18 M favors not only microbial replication but also the biofilm formation (56, 57) and persistence (44).”
BackgroundMetal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses
Corbin, B. D., Seeley, E. H., Raab, A., Feldmann, J., Miller, M. R., Torres, V. J., Anderson, K. L., Dattilo, B. M., Dunman, P. M., Gerads, R., et al. (2008) · Science · doi:10.1126/science.1152449 · Cited by 857
The role of lactic acid production by probiotic Lactobacillus species in vaginal health
Tachedjian, G., Aldunate, M., Bradshaw, C. S., & Cone, R. A. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.04.001 · Cited by 557
Lactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Lactoferrin: a natural Glycoprotein involved in iron and inflammatory homeostasis
Rosa, L., Cutone, A., Lepanto, M., Paesano, R., & Valenti, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091985 · Cited by 376 · cited 2×
“The main antimicrobial peptides and proteins present in the CVF are shown in Table 1 (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) .”
BackgroundSelf-citationO'Hanlon, D. E., Moench, T. R., & Cone, R. A. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-200 · Cited by 375 · cited 1×
“vaginalis and Atopobium vaginae were inactivated without effects on typical vaginal species of lactobacilli (67).”
BackgroundAntiviral properties of lactoferrin--a natural immunity molecule
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011) · Molecules · doi:10.3390/molecules16086992 · Cited by 356 · cited 1×
“This activity is mainly due to bLf binding to heparan sulfate glycosaminoglycan cell receptors or viral particles or both (45).”
BackgroundSelf-citationCharacterization of vaginal flora and bacterial vaginosis in women who have sex with women.
Marrazzo, J. M., Koutsky, L. A., Eschenbach, D. A., Agnew, K., Stine, K., & Hillier, S. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/339884 · Cited by 267 · cited 6×
“Int J Immunopathol Pharmacol (2005) 18(4):661–70.”
BackgroundInfluentialLegrand, D. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-056 · Cited by 193 · cited 2×
“Besides its role in cellular-mediated immunity, hLf influences activation of B cells, thus playing a role also in humoral responses (113).”
BackgroundCellular internalization of lactoferrin in intestinal epithelial cells
Ashida, K., Sasaki, H., Suzuki, Y. A., & Lönnerdal, B. (2004) · BioMetals · doi:10.1023/b:biom.0000027710.13543.3f · Cited by 117
Bradshaw, C. S., Walker, J., Fairley, C. K., Chen, M. Y., Tabrizi, S. N., Donovan, B., Kaldor, J. M., McNamee, K., Urban, E., Walker, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057688 · Cited by 95 · cited 1×
“Clinical trials based on Nugent score endpoint and questionnaires have revealed a reduced BV rate in women who use estrogen-containing contraceptives (135, 136).”
MethodMastromarino, P., Cacciotti, F., Masci, A., & Mosca, L. (2011) · Anaerobe · doi:10.1016/j.anaerobe.2011.04.022 · Cited by 77 · cited 2×
“A nonprotein cell wall component extracted from a vaginal strain of Lactobacillus brevis strongly reduces HSV-2 replication in cell culture (76) , whereas acid Lactobacillus metabolic products decrease activation of T lymphocytes, with a consequent lower lymphocyte susceptibility to HIV-1 infection (77) .”
BackgroundSuzuki, Y. A., Wong, H., Ashida, K.-Y., Schryvers, A. B., & Lönnerdal, B. (2008) · Biochemistry · doi:10.1021/bi8012164 · Cited by 75
Cited by
Kell, D. B., Heyden, E. L., & Pretorius, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01221 · Cited by 460
Wang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162
Lactoferrin in aseptic and septic inflammation
Lepanto, M. S., Rosa, L., Paesano, R., Valenti, P., & Cutone, A. (2019) · Molecules · doi:10.3390/molecules24071323 · Cited by 147
“The increase of Lf concentrations and its multi-functions represent an innate immune defence in the female reproductive tract [177].”
BackgroundLive Biotherapeutic Products, A Road Map for Safety Assessment
Rouanet, A., Bolca, S., Bru, A., Claes, I., Cvejic, H., Girgis, H., Harper, A., Lavergne, S. N., Mathys, S., Pane, M., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00237 · Cited by 120
Russo, R., Superti, F., Karadja, E., & De Seta, F. (2019) · Mycoses · doi:10.1111/myc.12883 · Cited by 94
Metadata
- Authors
- Valenti, P., Rosa, L., Capobianco, D., Lepanto, M. S., Schiavi, E., Cutone, A., Paesano, R., & Mastromarino, P.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-01
- Volume
- 9
- Pages
- 376-376
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2789501123
- Cited by
- 218
- References
- 14
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.